Preparation method of bionic system based on microfluidic technology, bionic system and application
An artificial cell system fabricated on a microfluidic chip using microfluidic technology in combination with raw materials such as chitosan, nanozymes, and alginate has solved the problem of constructing robust artificial cells with high throughput. It achieves efficient simulation of glucose metabolism and good mechanical properties, making it suitable for biomedical applications.
Patent Information
- Application Number
- CN202511773261.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-11-28
- Publication Date
- 2026-03-10
AI Technical Summary
Existing technologies struggle to construct robust artificial cells in a high-throughput, easy-to-operate, and controllable manner, especially in research on simulating glucose metabolism, which remains largely unresolved.
Using microfluidic technology, artificial cell systems with tunable morphology, structure, and activity are prepared on microfluidic chips through intermolecular polymerization reactions using raw materials such as chitosan, nanozymes, alginate, and phytic acid. Nanozymes with glucose oxidase-like and peroxidase-like activities are integrated to simulate glucose metabolism.
It achieves highly efficient catalytic glucose oxidation reaction with high preparation efficiency and good reproducibility. The artificial cells have similar catalytic activity and responsiveness to cells, good mechanical strength and permeability, and are suitable for long-term biomedical applications.
Smart Images

Figure CN121623880A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of functional biomimetic materials technology, and more specifically to a method for preparing a biomimetic system based on microfluidic technology, as well as the biomimetic system and its application. Background Technology
[0002] Bionic materials generally refer to artificial materials designed and manufactured to mimic the operational patterns of living systems and the structural principles of biological materials. Bionic design aims not only to simulate the structure of biological objects but also their functions. Combining materials science, life science, and bionics is of great significance for advancing the development of materials science.
[0003] In recent years, inspired by various substances, materials, and phenomena in nature, research on biomimetic materials has attracted the attention of researchers. Through continuous design and optimization, biomimetic tissues and organs such as artificial hearts, artificial livers, artificial kidneys, artificial blood vessels, artificial skin, artificial muscles, artificial nerves, and artificial cells have been reported.
[0004] Artificial cells are microcapsules that encapsulate bioactive substances (enzymes, coenzymes, or amino acids, etc.) using a polymer semi-permeable membrane to mimic the functions of human cells. Artificial cells not only hold promise for replacing natural cells in future research on the origin of life, but also have the potential to establish artificial cell factories in basic cell biology research. Despite their promising applications, research on artificial cells is still in its early stages, and much work remains to be done. Developing new methods and materials to construct novel artificial cell systems is of significant value.
[0005] Currently, researchers mainly employ two complementary approaches: top-down and bottom-up. Developing high-throughput, easy-to-operate, and controllable methods to construct robust "living" artificial cells is of great significance. Summary of the Invention
[0006] In view of this, the present invention provides a method for preparing a biomimetic system based on microfluidic technology, as well as the biomimetic system and its application. Using chitosan, nanozymes, alginate, phytic acid, etc., as raw materials, and through intermolecular polymerization reactions using a microfluidic chip, a high-throughput artificial cell system with tunable morphology, structure, and activity is prepared. The prepared artificial cell system can simulate glucose metabolism.
[0007] To achieve the above objectives, the present invention adopts the following technical solution: A method for fabricating a biomimetic system based on microfluidic technology includes the following steps: (1) Take deionized water and put it in a container. Add acetic acid and dilute it thoroughly. Then add polysaccharide powder and stir it at room temperature for a period of time with a magnetic stirrer to obtain the first solution. Divide it into two equal portions for later use. (2) Take a nanozyme with glucose oxidase-like activity and add it to the first solution, and stir it at room temperature for a period of time using a magnetic stirrer to obtain the second solution; (3) Take a nanozyme with peroxidase-like activity and add it to the first solution that is evenly divided. Stir it at room temperature for a period of time using a magnetic stirrer to obtain the third solution. (4) Take deionized water and place it in a container, add phytic acid, and stir it at room temperature for a period of time using a magnetic stirrer to obtain the fourth solution; (5) Take deionized water and put it in a beaker, add alginate, and stir it at room temperature for a period of time using a magnetic stirrer to obtain the fifth solution; (6) Take deionized water and put it in a beaker, add calcium chloride, stir it at room temperature for a period of time using a magnetic stirrer, and then stop the reaction to obtain the sixth solution; (7) Design a multi-channel microfluidic chip using CAD software, and fabricate the microfluidic chip using PDMS as raw material by soft photolithography. The microfluidic chip includes inlet 1, inlet 2, inlet 3, inlet 4, inlet 5, inlet 6, inlet 7, inlet 8, reactor R1, reactor R2, reactor R3, mixer M and outlet. (8) The fourth solution is injected through inlet 1, inlet 3, inlet 4 and inlet 6 using a peristaltic pump, the second solution is injected through inlet 2 at a flow rate of 0.1-100 μL / min, the third solution is injected through inlet 5 at a flow rate of 0.1-100 μL / min, the reaction solution of inlet 1, inlet 2 and inlet 3 enters reactor R1, the reaction solution of inlet 4, inlet 5 and inlet 6 enters reactor R2, and the solutions in reactor R1 and reactor R2 are combined to obtain the seventh solution; (9) The seventh intermediate product solution enters the mixer M and is mixed with the fifth solution injected into the mixer M through the injection port 7 to obtain the eighth solution; (10) The sixth solution is injected through the injection port 8 using a peristaltic pump. The sixth solution reacts with the eighth solution through reactor R3 to obtain the final product, the ninth solution, which is the artificial cell bionic system.
[0008] The artificial cell system prepared by the method of this invention exhibits excellent cell activity and can mimic the glucose metabolism process. It includes the following steps: (1) The obtained artificial cell biomimetic system was dispersed in HAc-NaAc buffer solution with pH 4.5. 10-50 μL of glucose solution with mass concentration of 5-10 mg / mL and 20 μL of TMB solution with mass concentration of 5 mg / mL were added to the above buffer solution. The ultraviolet absorption change of the reaction solution was measured using an ultraviolet spectrophotometer.
[0009] In this invention, chitosan is used as the main structural material. The amino groups in its molecules can undergo ionic cross-linking with the phosphate groups of phytic acid to form a stable polyelectrolyte complex membrane, thereby constructing the basic framework of artificial cells. This cross-linking reaction is highly controllable, effectively mimicking the semi-permeability of cell membranes and providing mechanical strength to the artificial cells. The charge properties of chitosan contribute to the immobilization and activity maintenance of nanozymes.
[0010] In this invention, alginate serves as an encapsulation material, providing additional structural support and controllable permeability to help encapsulate nanozymes and other components, mimicking the extracellular matrix. Its excellent gelling and biodegradability endows the artificial cells with a microenvironment similar to natural cells, facilitating the diffusion of nutrients and metabolites.
[0011] In this invention, phytic acid acts as a cross-linking agent, undergoing an intermolecular polymerization reaction with the amino groups of chitosan to form a stable polyelectrolyte complex. This cross-linking reaction not only enhances the structural integrity of the artificial cell but also regulates its porosity and stability, thereby controlling mass transport and enzyme reaction rates and mimicking the dynamic behavior of the cell membrane.
[0012] In this invention, calcium chloride provides calcium ions as a crosslinking agent for alginate, promoting the rapid formation of alginate into a hydrogel. This crosslinking reaction can be controlled within a microfluidic chip, resulting in artificial cells with uniform size and shape, while simultaneously improving mechanical strength and long-term stability.
[0013] Preferably, in step (1), the mass ratio of acetic acid to polysaccharide powder is (2-4):(1-8); the stirring speed is 600 r / min and the stirring time is 240 min; the polysaccharide powder is chitin, chitosan or cellulose.
[0014] Preferably, in step (2), the stirring speed is 600 r / min and the stirring time is 60 min; the concentration of the nanozyme with glucose oxidase-like activity in the second solution is 5-10 mg / ml; In step (3), the stirring speed is 600 r / min and the stirring time is 60 min; the concentration of the peroxidase-like nanozyme in the third solution is 5-10 mg / ml.
[0015] Preferably, the nanozyme with glucose oxidase-like activity is a gold nanodot, gold nanocluster, gold nanosheet, gold nanoribbon, gold nanosphere, gold nanorod, or gold nanoring.
[0016] Preferably, the nanozyme with peroxidase-like activity is iron oxide nanodots, iron oxide nanosheets, iron oxide nanoribbons, iron oxide nanospheres, iron oxide nanorods, or iron oxide rings.
[0017] Preferably, in step (4), the stirring speed is 600 r / min and the stirring time is 30 min; the concentration of phytic acid in the fourth solution is 10-80 mg / ml; In step (5), the stirring speed is 600 r / min and the stirring time is 60 min; the concentration of alginate in the fifth solution is 20-40 mg / ml; the alginate is sodium alginate, potassium alginate, calcium alginate, zinc alginate or magnesium alginate.
[0018] Preferably, in step (6), the stirring speed is 600 r / min and the stirring time is 15 min; the concentration of calcium chloride in the sixth solution is 20-40 mg / ml.
[0019] Preferably, the channel dimensions of the microfluidic chip are as follows: the width of the microchannel is 50-200 μm, the height is 35-55 μm, and the length is 5-15 cm; the diameters of reactors R1, R2, and R3 are 3-6 cm; and the diameter of mixer M is 1-2 cm.
[0020] Another object of the present invention is to provide a biomimetic system based on microfluidic technology, which is prepared by the above-described method.
[0021] Another objective of this invention is to provide the application of the biomimetic system prepared by the above-mentioned method based on microfluidic technology in the field of biomedical manufacturing.
[0022] As can be seen from the above technical solution, compared with the prior art, the present invention has the following technical effects: (1) By utilizing the multi-channel design of microfluidic chips, reaction conditions can be precisely controlled to achieve large-scale production of artificial cells with adjustable morphology, structure and activity, with high preparation efficiency and good reproducibility.
[0023] (2) By integrating nanozymes with glucose oxidase and peroxidase-like activities, the artificial system can efficiently catalyze the glucose oxidation reaction and produce detectable changes in ultraviolet absorption, successfully mimicking the glucose metabolism pathway of natural cells and exhibiting catalytic activity and responsiveness similar to cells.
[0024] (3) Based on the composite structure of chitosan-phytic acid-alginate, artificial cells have good mechanical strength, permeability and biocompatibility. Nanozymes maintain high catalytic activity after encapsulation and are suitable for long-term operation and biomedical applications.
[0025] (4) By adjusting the raw material concentration, nanozyme type or microfluidic parameters, the function of artificial cells can be customized, providing a new platform for artificial cell research and biomimetic system development. Attached Figure Description
[0026] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.
[0027] Figure 1 This is a schematic diagram of the microfluidic chip designed in Embodiment 1 of the present invention; Figure 2 This is a microscope image of the artificial cell system prepared using a microfluidic chip in Embodiment 1 of the present invention; Figure 3 This is an ultraviolet (UV) analysis diagram of the artificial cell system synthesized in Example 1 of the present invention, mimicking glucose metabolism. Detailed Implementation
[0028] The technical solutions in the embodiments of the present invention will be clearly and completely described below. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.
[0029] Example 1 Step 1: Take 200 mL of deionized water and put it in a beaker. Add 4 g of acetic acid and after it is fully diluted, add 2 g of chitosan powder. Stir at room temperature for 240 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the first solution, and divide it into two equal portions for later use. Step 2: Take 500 mg of gold nanosheets with glucose oxidase-like activity and add them to the first solution. Stir the solution at room temperature for 60 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the second solution. Step 3: Take 500 mg of iron oxide nanospheres with peroxidase-like activity and add them to the first solution. Stir the solution at room temperature for 60 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the third solution. Step 4: Take 200 mL of deionized water and put it in a beaker. Add 2 g of phytic acid and stir at room temperature for 30 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the fourth solution. Step 5: Take 200 mL of deionized water and put it in a beaker. Add 4 g of sodium alginate and stir at room temperature for 60 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the fifth solution. Step 6: Take 200 mL of deionized water and put it in a beaker. Add 4 g of calcium chloride and stir at room temperature for 15 min using a magnetic stirrer with a stirring speed of 600 r / min. Then stop the reaction to obtain the sixth solution. Step 7: Design a multi-channel microfluidic chip using CAD software, and fabricate the microfluidic chip using PDMS as the raw material via soft photolithography. The channel dimensions of the microfluidic chip are: a width of 50 μm, a height of 35 μm, and a length of 5 cm. The microfluidic chip includes eight inlets (1, 2, 3, 4, 5, 6, 7, and 8), three reactors (R1, R2, and R3) with a diameter of 3 cm, a mixer (M) with a diameter of 1 cm, and an outlet.
[0030] Step 8: Using a peristaltic pump, inject the fourth solution through inlets 1, 3, 4, and 6; inject the second solution through inlet 2; and inject the third solution through inlet 5. The reaction solutions from inlets 1, 2, and 3 enter reactor R1, and the reaction solutions from inlets 4, 5, and 6 enter reactor R2, yielding the seventh solution. Step 9: The seventh intermediate solution enters the mixer M and is mixed with the fifth solution injected through the injection port 7 to obtain the eighth solution; Step 10: The sixth solution is injected through the inlet 8 using a peristaltic pump. The sixth solution reacts with the eighth solution through reactor R3 to obtain the final product, the ninth solution, which is the artificial cell biomimetic system.
[0031] Example 2 Step 1: Take 200 mL of deionized water and put it in a beaker. Add 8 g of acetic acid and after it is fully diluted, add 2 g of chitosan powder. Stir at room temperature for 240 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the first solution, and divide it into two equal portions for later use. Step 2: Take 1000 mg of gold nanowires with glucose oxidase-like activity and add them to the first solution. Stir the solution at room temperature for 60 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the second solution. Step 3: Take 1000 mg of iron oxide nanorods with peroxidase-like activity and add them to the first solution. Stir the solution at room temperature for 60 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the third solution. Step 4: Take 200 mL of deionized water and put it in a beaker. Add 16 g of phytic acid and stir at room temperature for 30 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the fourth solution. Step 5: Take 200 mL of deionized water and put it in a beaker. Add 8 g of alginate and stir at room temperature for 60 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the fifth solution. Step 6: Take 200 mL of deionized water and put it in a beaker. Add 8 g of calcium chloride and stir at room temperature for 15 min using a magnetic stirrer with a stirring speed of 600 r / min. Then stop the reaction to obtain the sixth solution. Step 7: Design a multi-channel microfluidic chip using CAD software, and fabricate the microfluidic chip using PDMS as the raw material via soft photolithography. The channel dimensions of the microfluidic chip are: a width of 200 μm, a height of 55 μm, and a length of 15 cm. The microfluidic chip includes eight inlets (1, 2, 3, 4, 5, 6, 7, and 8), three reactors (R1, R2, and R3) with a diameter of 6 cm, a mixer (M) with a diameter of 2 cm, and an outlet.
[0032] Step 8: Using a peristaltic pump, inject the fourth solution through inlets 1, 3, 4, and 6; inject the second solution through inlet 2 at a flow rate of 100 μL / min; and inject the third solution through inlet 5 at a flow rate of 100 μL / min. The reaction solutions from inlets 1, 2, and 3 enter reactor R1, and the reaction solutions from inlets 4, 5, and 6 enter reactor R2, yielding the seventh solution. Step 9: The seventh intermediate solution enters the mixer M and is mixed with the fifth solution injected through the injection port 7 to obtain the eighth solution; Step 10: The sixth solution is injected through the inlet 8 using a peristaltic pump. The sixth solution reacts with the eighth solution through reactor R3 to obtain the final product, the ninth solution, which is the artificial cell biomimetic system.
[0033] Example 3 Step 1: Take 200 mL of deionized water and put it in a beaker. Add 4 g of acetic acid and after it is fully diluted, add 2 g of chitosan powder. Stir at room temperature for 240 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the first solution, and divide it into two equal portions for later use. Step 2: Take 5000 mg of gold nanodots with glucose oxidase-like activity and add them to the first solution. Stir the solution at room temperature for 60 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the second solution. Step 3: Take 5000 mg of iron oxide nanorings with peroxidase-like activity and add them to the first solution. Stir the solution at room temperature for 60 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the third solution. Step 4: Take 200 mL of deionized water and put it in a beaker. Add 16 g of phytic acid and stir at room temperature for 30 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the fourth solution. Step 5: Take 200 mL of deionized water and put it in a beaker. Add 8 g of potassium alginate and stir at room temperature for 60 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the fifth solution. Step 6: Take 200 mL of deionized water and put it in a beaker. Add 8 g of calcium chloride and stir at room temperature for 15 min using a magnetic stirrer with a stirring speed of 600 r / min. Then stop the reaction to obtain the sixth solution. Step 7: Design a multi-channel microfluidic chip using CAD software, and fabricate the microfluidic chip using PDMS as the raw material via soft photolithography. The channel dimensions of the microfluidic chip are: a width of 50 μm, a height of 35 μm, and a length of 15 cm. The microfluidic chip includes eight inlets (1, 2, 3, 4, 5, 6, 7, and 8), three reactors (R1, R2, and R3) with a diameter of 3 cm, a mixer (M) with a diameter of 1 cm, and an outlet.
[0034] Step 8: Using a peristaltic pump, inject the fourth solution through inlets 1, 3, 4, and 6; inject the second solution through inlet 2 at a flow rate of 0.1 μL / min; and inject the third solution through inlet 5 at a flow rate of 0.1 μL / min. The reaction solutions from inlets 1, 2, and 3 enter reactor R1, and the reaction solutions from inlets 4, 5, and 6 enter reactor R2, yielding the seventh solution. Step 9: The seventh intermediate solution enters the mixer M and is mixed with the fifth solution injected through the injection port 7 to obtain the eighth solution; Step 10: The sixth solution is injected through the inlet 8 using a peristaltic pump. The sixth solution reacts with the eighth solution through reactor R3 to obtain the final product, the ninth solution, which is the artificial cell biomimetic system.
[0035] Example 4 Step 1: Take 200 mL of deionized water and put it in a beaker. Add 8 g of acetic acid and after it is fully diluted, add 2 g of polysaccharide powder. Stir at room temperature for 240 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the first solution, and divide it into two equal portions for later use. Step 2: Take 500 mg of gold nanorings with glucose oxidase-like activity and add them to the first solution. Stir the solution at room temperature for 60 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the second solution. Step 3: Take 500 mg of iron oxide nanowires with peroxidase-like activity and add them to the first solution. Stir the solution at room temperature for 60 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the third solution. Step 4: Take 200 mL of deionized water and put it in a beaker. Add 2 g of phytic acid and stir at room temperature for 30 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the fourth solution. Step 5: Take 200 mL of deionized water and put it in a beaker. Add 4 g of alginate enzyme and stir at room temperature for 60 min using a magnetic stirrer with a stirring speed of 600 r / min to obtain the fifth solution. Step 6: Take 200 mL of deionized water and put it in a beaker. Add 4 g of calcium chloride and stir at room temperature for 15 min using a magnetic stirrer with a stirring speed of 600 r / min. Then stop the reaction to obtain the sixth solution. Step 7: Design a multi-channel microfluidic chip using CAD software, and fabricate the microfluidic chip using PDMS as the raw material via soft photolithography. The channel dimensions of the microfluidic chip are: a width of 200 μm, a height of 35 μm, and a length of 5 cm. This microfluidic chip includes eight inlets (1, 2, 3, 4, 5, 6, 7, and 8), three reactors (R1, R2, and R3) with a diameter of 6 cm, a mixer (M) with a diameter of 2 cm, and an outlet.
[0036] Step 8: Using a peristaltic pump, inject the fourth solution through inlets 1, 3, 4, and 6; inject the second solution through inlet 2 at a flow rate of 100 μL / min; and inject the third solution through inlet 5 at a flow rate of 100 μL / min. The reaction solutions from inlets 1, 2, and 3 enter reactor R1, and the reaction solutions from inlets 4, 5, and 6 enter reactor R2, yielding the seventh solution. Step 9: The seventh intermediate solution enters the mixer M and is mixed with the fifth solution injected through the injection port 7 to obtain the eighth solution; Step 10: The sixth solution is injected through the inlet 8 using a peristaltic pump. The sixth solution reacts with the eighth solution through reactor R3 to obtain the final product, the ninth solution, which is the artificial cell biomimetic system.
[0037] Artificial cell systems fabricated using microfluidic technology simulate glucose metabolism: Application Example 1 Step 1: The obtained artificial cell biomimetic system is dispersed in HAc-NaAc buffer solution with a pH of 4.5. 10 μL of glucose solution with a mass concentration of 5 mg / mL and 20 μL of TMB solution with a mass concentration of 5 mg / mL are added to the above buffer solution. The change in UV absorption of the reaction solution is measured using a UV spectrophotometer.
[0038] Application Example 2 Step 1: Disperse the obtained artificial cell biomimetic system in HAc-NaAc buffer solution with a pH of 4.5. Add 50 μL of glucose solution with a mass concentration of 10 mg / mL and 20 μL of TMB solution with a mass concentration of 5 mg / mL to the above buffer solution. Measure the change in UV absorption of the reaction solution using a UV spectrophotometer.
[0039] To verify the necessity and synergistic effect of each raw material in this invention, the following comparative examples were designed. Except for specified modifications, all steps in the comparative examples were consistent with those in Example 1 of this invention. Similarly, 10 μL of 5 mg / mL glucose solution and 20 μL of 5 mg / mL TMB solution were added to a pH 4.5 HAc-NaAc buffer solution. The change in absorbance of the solution was measured at 652 nm using a UV spectrophotometer to evaluate its activity in simulating glucose metabolism.
[0040] Comparative Example 1 In step 1, without adding chitosan or other polysaccharide powders, a stable first solution cannot be formed, and effective ionic cross-linking with phytic acid cannot occur in subsequent steps. Stable droplet or microcapsule structures cannot be formed in the microfluidic chip. The final product is a turbid, unstructured suspension, rather than "artificial cells" with a defined morphology. In activity testing, there was no significant change in UV absorption.
[0041] Comparative Example 2 In step 4, phytic acid was not added, and the fourth solution consisted only of deionized water. Due to the lack of phytic acid as a cross-linking agent, the chitosan chains could not cross-link with the amino groups via phosphate groups to form a robust polyelectrolyte membrane. In the reactors R1 and R2 of the microfluidic chip, the structure was loose, and the formed "precursor cells" had extremely poor strength, easily rupturing during subsequent flow. The final product exhibited an uneven morphology, and activity testing showed that the UV absorbance was far lower than in Example 1, indicating that the nanozyme was significantly lost or inactivated due to poor encapsulation. This comparative example demonstrates that phytic acid is a key cross-linking agent for achieving effective cross-linking of chitosan and forming a stable cell-mimicking structure.
[0042] Comparative Example 3 In step 5, without the addition of alginate, the fifth solution consists only of deionized water. In mixer M, the encapsulation effect of alginate is lacking. Upon entering reactor R3, even with calcium chloride, an additional calcium alginate hydrogel protective layer cannot be formed. This reduces the mechanical strength and stability of the artificial cell system, making it less resistant to changes in the external environment. While initial absorption changes may be observed during activity testing, catalytic activity rapidly declines after repeated testing or prolonged storage. This comparative example demonstrates that alginate provides crucial secondary encapsulation and stabilization, enhancing the robustness and lifespan of the artificial cells.
[0043] Comparative Example 4 In step 6, without the addition of calcium chloride, the sixth solution consisted only of deionized water. Alginate could not cross-link and solidify. In step 10, the eighth solution (containing alginate) failed to form the final gel structure. The product was a viscous, amorphous fluid, and discrete "artificial cells" could not be separated. The nanozyme was unevenly dispersed, and activity tests showed a slow reaction and very low absorbance changes. This comparative example demonstrates that calcium chloride is a necessary factor in activating alginate gelation and achieving the transformation from a fluid to a cellular solid structure.
[0044] The various embodiments in this specification are described in a progressive manner, with each embodiment focusing on its differences from other embodiments. Similar or identical parts between embodiments can be referred to interchangeably. For the apparatus disclosed in the embodiments, since they correspond to the methods disclosed in the embodiments, the description is relatively simple; relevant parts can be referred to the method section.
[0045] The above description of the disclosed embodiments enables those skilled in the art to make or use the invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the invention. Therefore, the invention is not to be limited to the embodiments shown herein, but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims
1. A method for preparing a biomimetic system based on microfluidic technology, characterized in that, Comprise the following steps: (1) Take deionized water in a container, add acetic acid, after dilution, add polysaccharide powder, use magnetic stirrer to stir at room temperature for a period of time, get the first solution, and divide into two parts equally for standby; (2) Take nanoscale enzyme with glucose oxidase activity into the first solution, use magnetic stirrer to stir at room temperature for a period of time, get the second solution; (3) Take nanoscale enzyme with peroxidase activity into the first solution, use magnetic stirrer to stir at room temperature for a period of time, get the third solution; (4) Take deionized water in a container, add phytic acid, use magnetic stirrer to stir at room temperature for a period of time, get the fourth solution; (5) Take deionized water in a beaker, add alginate, use magnetic stirrer to stir at room temperature for a period of time, get the fifth solution; (6) Take deionized water in a beaker, add calcium chloride, use magnetic stirrer to stir at room temperature for a period of time, then stop the reaction, get the sixth solution; (7) Use CAD software to design a multi-channel microfluidic chip, use PDMS as raw material to prepare microfluidic chip by soft lithography method, the microfluidic chip comprises sample inlet 1, sample inlet 2, sample inlet 3, sample inlet 4, sample inlet 5, sample inlet 6, sample inlet 7, sample inlet 8, reactor R1, reactor R2, reactor R3, mixer M and sample outlet; (8) Use peristaltic pump to inject fourth solution through sample inlet 1, sample inlet 3, sample inlet 4 and sample inlet 6, inject second solution through sample inlet 2, flow rate is 0.1-100 μL / min, inject third solution through sample inlet 5, flow rate is 0.1-100 μL / min, reaction liquid of sample inlet 1, sample inlet 2 and sample inlet 3 enters reactor R1, reaction liquid of sample inlet 4, sample inlet 5 and sample inlet 6 enters reactor R2, the solution in reactor R1 and reactor R2 is collected to get the seventh solution; (9) The seventh solution enters the mixer M and mixes with the fifth solution injected into the mixer M through the sample inlet 7 to get the eighth solution; (10) Use peristaltic pump to inject sixth solution through sample inlet 8, the sixth solution reacts with the eighth solution through reactor R3 to get the final product ninth solution, namely artificial cell biomimetic system.
2. The method of claim 1, wherein the method comprises: The mass ratio of acetic acid to polysaccharide powder in step (1) is (2-4):(1-8); the stirring speed is 600 r / min, and the stirring time is 240 min; the polysaccharide powder is chitin, chitosan or cellulose.
3. The method of claim 1, wherein the method further comprises: The stirring speed in step (2) is 600 r / min, and the stirring time is 60 min; the concentration of nanoscale enzyme with glucose oxidase activity in the second solution is 5-10 mg / ml; The stirring speed in step (3) is 600 r / min, and the stirring time is 60 min; the concentration of nanoscale enzyme with peroxidase activity in the third solution is 5-10 mg / ml.
4. The method of claim 3, wherein the method further comprises: The nanoscale enzyme with glucose oxidase activity is gold nanodot, gold nanocluster, gold nanosheet, gold nanobelt, gold nanosphere, gold nanorod or gold nanoring.
5. The method of claim 3, wherein the method further comprises the step of: The nano-enzyme with peroxidase-like activity is a ferroferric oxide nanoparticle, a ferroferric oxide nanosheet, a ferroferric oxide nanobelt, a ferroferric oxide nanosphere, a ferroferric oxide nanorod or a ferroferric oxide nanoring. 6. The method of claim 1, wherein the method further comprises: The stirring speed in step (4) is 600 r / min, and the stirring time is 30 min; the concentration of phytic acid in the fourth solution is 10-80 mg / ml; The stirring speed in step (5) is 600 r / min, and the stirring time is 60 min; the concentration of alginate in the fifth solution is 20-40 mg / ml; the alginate is sodium alginate, potassium alginate, calcium alginate, zinc alginate or magnesium alginate.
7. The method of claim 1, wherein the method further comprises: providing a microfluidic chip; and providing a microfluidic chip. The stirring speed in step (6) is 600 r / min, and the stirring time is 15 min; the concentration of calcium chloride in the sixth solution is 20-40 mg / ml.
8. The method of claim 1, wherein the method further comprises: providing a microfluidic chip; and providing a microfluidic chip. The channel size of the microfluidic chip is that the width of the microfluidic channel is 50-200 μm, the height is 35-55 μm, and the length is 5-15 cm; the diameter of the reactor R1, the reactor R2 and the reactor R3 is 3-6 cm; and the diameter of the mixer M is 1-2 cm.
9. A biomimetic system based on microfluidics technology, characterized in that, Prepared by the preparation method of any one of claims 1-8.
10. Application of the microfluidic technology-based bionic system of claim 9 in the field of biopharmaceutical manufacturing.
